Modulation of Mhc Antigen Expression and Disease (Paperback)

1. General introduction to the MHC Lynda G. Tussey and Andrew J. McMichael; 2. Organisation of the MHC Jiannis Ragoussis; 3. Interactions of cytokines in the regulation of MHC class I and class II antigen expression Ian Todd; 4. Control of MHC class I gene expression Keiko Ozato; 5. Control of MHC class II gene expression Jenny Pan-Yun Ting and Barbara J. Vilen; 6. Modulation of MHC antigen expression by viruses D. John Maudsley; 7. Modulation of MHC antigen expression by retroviruses Douglas V. Faller; 8. Modulation of MHC class I antigen expression in adenovirus expression and transformation G. Eric Blair, Joanne L. Proffitt and Maria E. Blair Zajdel; 9. MHC expression in HPV-associated cervical cancer Jennifer Bartholomew, John M. Tinsley and Peter L. Stern; 10. Inhibition of the cellular response to interferon by hepatitus B virus polymerase Graham R. Foster; 11. Cellular adhesion molecules and MHC antigens in cells infected with Epstein/Barr virus: implications for immune recognition Martin Rowe and Maria G. Masucci; 12. Effect of human cytomegalovirus infection on the expression of MHC class I antigens and adhesion molecules: potential role in immune evasion and immunopathology Jane E. Grundy; 13. Oncogenes and MHC class I expression Lucy T. C. Peltenburg and Peter I. Schrier; 14. Mechanisms of tumour cell killing and the role of MHC antigens in experimental model systems Roger F. L. James; 15. Manipulation of MHC antigens by gene transfection and cytokine stimulation: a possible approach for pre-selection of suitable patients for cytokine therapy Ame Nouri; 16. Overexpression of MHC proteins in pancreatic islets: a link between cytokines, viruses, the breach of tolerance and insulin dependent diabetes mellitus? M. Vives-Pi, N. Somoza, F. Vargas and R. Pujol-Borrell; 17. The role of cytokines in contributing to MHC antigen expression in rheumatoid arthritis Fionula M. Brennan; 18. Expression of an MHC antigen in the central nervous system: an animal model for demyelinating diseases Lionel Feigenbaum, Taduru Sreenath and Gilbert Jay.